Page 1 of Clinical Trials for Drug Ezetimibe Simvastatin 10 20 mg, 35 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Withdrawn
Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
Last Updated: October 21, 2011
Condition(s): Cardiovascular Diseases; Hyperlipidemia
2
Not yet recruiting
Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes
Last Updated: August 18, 2010
Condition(s): Type 2 Diabetes Mellitus Without Insulin Treatment
3
Completed
Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)
Last Updated: September 22, 2011
Condition(s): Hypercholesterolemia
4
Completed
Effects of Vytorin Versus Placebo in Subjects With Primary Hypercholesterolemia (Study P04420)(COMPLETED)
Last Updated: June 3, 2010
Condition(s): Hypercholesterolemia
5
Completed
Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction
Last Updated: March 23, 2010
Condition(s): Myocardial Infarction
6
Completed
A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)
Last Updated: September 23, 2010
Condition(s): Hypercholesterolemia
7
Completed
Vytorin Reexamination Study (0653A-174)
Last Updated: April 14, 2011
Condition(s): Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
8
Completed
EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)
Last Updated: September 5, 2008
Condition(s): Atherosclerosis
9
Completed
The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
Last Updated: October 13, 2009
Condition(s): Hypercholesterolemia; Coronary Disease
10
Completed
A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet
Last Updated: November 30, 2007
Condition(s): Hyperlipidemia
11
Completed
Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
Last Updated: March 26, 2012
Condition(s): Cardiovascular Disorder; Diabetes Mellitus
12
Completed
Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)(COMPLETED)
Last Updated: March 17, 2010
Condition(s): Hypercholesterolemia
13
Completed
Effect of Ezetimibe or Simvastatin or Both on LDL-Subfractions in Patients With Type 2 Diabetes
Last Updated: June 29, 2011
Condition(s): Diabetes Mellitus Type 2; Hypercholesterolemia
14
Completed
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease
Last Updated: January 21, 2010
Condition(s): Hypercholesterolemia; Coronary Disease
15
Completed
Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease
Last Updated: April 20, 2010
Condition(s): Hypercholesterolemia
16
Terminated
Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)(TERMINATED)
Last Updated: April 1, 2008
Condition(s): Hypercholesterolemia; Atherosclerosis
17
Not yet recruiting
Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome.
Last Updated: October 5, 2009
Condition(s): Metabolic Syndrome
18
Completed
Co-Administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease
Last Updated: May 17, 2006
Condition(s): Hypercholesterolemia; Coronary Disease
19
Completed
Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe
Last Updated: June 18, 2010
Condition(s): Stable Angina
20
Completed
A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea
Last Updated: April 20, 2010
Condition(s): Hypercholesterolemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Ezetimibe+Simvastatin+10+20+mg

Page 1 of Clinical Trials for Drug Ezetimibe Simvastatin 10 20 mg, 35 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About